Technical Analysis for AEZS - Aeterna Zentaris Inc

Grade Last Price % Change Price Change
grade A 4.75 -1.66% -0.080
AEZS closed down 1.66 percent on Tuesday, January 22, 2019, on 67 percent of normal volume. The price action carved out a bullish hammer (or hammer-like) candlestick pattern. That may indicate an upside reversal. Look for price to trade above the high of the hammer for confirmation.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Up Down
See historical AEZS trend table...

Date Alert Name Type % Chg
Jan 22 Hammer Candlestick Bullish 0.00%
Jan 22 Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
Jan 22 Calm After Storm Range Contraction 0.00%
Jan 22 Wide Bands Range Expansion 0.00%
Jan 21 180 Bullish Setup Bullish Swing Setup -1.66%
Jan 21 Non-ADX 1,2,3,4 Bullish Bullish Swing Setup -1.66%
Jan 21 Calm After Storm Range Contraction -1.66%
Jan 21 NR7 Range Contraction -1.66%
Jan 21 Wide Bands Range Expansion -1.66%
Jan 18 Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.85%

Older signals for AEZS ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Aeterna Zentaris Inc is a specialty biopharmaceutical company engaged in developing and commercializing treatments in oncology, endocrinology and women's health. The Company operates through the biopharmaceutical segment. The Company is engaged in drug development activities and in the promotion of products for others. The Company's principal product candidates are Zoptrex (zoptarelin doxorubicin) and Macrilen (macimorelin) in oncology and endocrinology. The Company focuses on its product candidates Zoptrex and Macrilen, which are in Phase III clinical development, and on a luteinizing hormone-releasing hormone (LHRH)-disorazol Z conjugate (AEZS-138), which is in pre-clinical development in oncology and is available for partnering. The Company's direct and indirect subsidiaries include AEZS GmbH, Zentaris IVF GmbH and Aeterna Zentaris, Inc.
Is AEZS a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 5.47
52 Week Low 1.5
Average Volume 45,151
200-Day Moving Average 2.8174
50-Day Moving Average 4.2072
20-Day Moving Average 4.473
10-Day Moving Average 4.852
Average True Range 0.3638
ADX 22.37
+DI 23.3379
-DI 19.6315
Chandelier Exit (Long, 3 ATRs ) 4.3786
Chandelier Exit (Short, 3 ATRs ) 4.4714
Upper Bollinger Band 5.4553
Lower Bollinger Band 3.4907
Percent B (%b) 0.64
BandWidth 43.921306
MACD Line 0.2431
MACD Signal Line 0.2409
MACD Histogram 0.0022
Fundamentals Value
Market Cap 76.53 Million
Num Shares 16.1 Million
EPS -1.71
Price-to-Earnings (P/E) Ratio -2.78
Price-to-Sales 42.62
Price-to-Book 5.01
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 5.095
Resistance 3 (R3) 5.067 4.923 5.038
Resistance 2 (R2) 4.923 4.835 4.938 5.018
Resistance 1 (R1) 4.837 4.781 4.765 4.865 4.999
Pivot Point 4.693 4.693 4.658 4.708 4.693
Support 1 (S1) 4.607 4.605 4.535 4.635 4.501
Support 2 (S2) 4.463 4.551 4.478 4.482
Support 3 (S3) 4.377 4.463 4.463
Support 4 (S4) 4.405